Any feedback?
Please rate this page
(sequences.php)
(0/150)

BRENDA support

Sequence of S5A2_HUMAN

EC Number:1.3.1.22

EC Number
Recommended Name
Accession Code
Organism
No of amino acids
Molecular Weight [Da]
Source
3-oxo-5alpha-steroid 4-dehydrogenase (NADP+)
P31213
Homo sapiens
254
28393
Reaction
a 3-oxo-5alpha-steroid + NADP+ = a 3-oxo-DELTA4-steroid + NADPH + H+
Other sequences found for EC No. 1.3.1.22

General information:

Sequence
show sequence in fasta format
  0 MQVQCQQSPV LAGSATLVAL GALALYVAKP SGYGKHTESL KPAATRLPAR AAWFLQELPS
 60 FAVPAGILAR QPLSLFGPPG TVLLGLFCVH YFHRTFVYSL LNRGRPYPAI LILRGTAFCT
120 GNGVLQGYYL IYCAEYPDGW YTDIRFSLGV FLFILGMGIN IHSDYILRQL RKPGEISYRI
180 PQGGLFTYVS GANFLGEIIE WIGYALATWS LPALAFAFFS LCFLGLRAFH HHRFYLKMFE
240 DYPKSRKALI PFIF
Download this sequence
in fasta format
Download all sequences for 1.3.1.22
in fasta format
in csv (Excel, OpenOffice) format
Sequence related references
Sequence Reference
Authors
Title
Journal
Volume
Pages
Year
PubMed ID
96693
Andersson S.,Berman D.M.,Jenkins E.P.,Russell D.W.
Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism.
Nature
354
159-161
1991
96694
Labrie F.,Sugimoto Y.,Luu-The V.,Simard J.,Lachance Y.,Bachvarov D.,Leblanc G.,Durocher F.,Paquet N.
Structure of human type II 5 alpha-reductase gene.
Endocrinology
131
1571-1573
1992
96697
Ota T.,Suzuki Y.,Nishikawa T.,Otsuki T.,Sugiyama T.,Irie R.,Wakamatsu A.,Hayashi K.,Sato H.,Nagai K.,Kimura K.,Makita H.,Sekine M.,Obayashi M.,Nishi T.,Shibahara T.,Tanaka T.,Ishii S.,Yamamoto J.,Saito K.,Kawai Y.,Isono Y.,Nakamura Y.,Nagahari K.,Murakami K.,Yasuda T.,Iwayanagi T.,Wagatsuma M.,Shiratori A.,Sudo H.,Hosoiri T.,Kaku Y.,Kodaira H.,Kondo H.,Sugawara M.,Takahashi M.,Kanda K.,Yokoi T.,Furuya T.,Kikkawa E.,Omura Y.,Abe K.,Kamihara K.,Katsuta N.,Sato K.,Tanikawa M.,Yamazaki M.,Ninomiya K.,Ishibashi T.,Yamashita H.,Murakawa K.,Fujimori K.,Tanai H.,Kimata M.,Watanabe M.,Hiraoka S.,Chiba Y.,Ishida S.,Ono Y.,Takiguchi S.,Watanabe S.,Yosida M.,Hotuta T.,Kusano J.,Kanehori K.,Takahashi-Fujii A.,Hara H.,Tanase T.-O.,Nomura Y.,Togiya S.,Komai F.,Hara R.,Takeuchi K.,Arita M.,Imose N.,Musashino K.,Yuuki H.,Oshima A.,Sasaki N.,Aotsuka S.,Yoshikawa Y.,Matsunawa H.,Ichihara T.,Shiohata N.,Sano S.,Moriya S.,Momiyama H.,Satoh N.,Takami S.,Terashima Y.,Suzuki O.,Nakagawa S.,Senoh A.,Mizoguchi H.,Goto Y.,Shimizu F.,Wakebe H.,Hishigaki H.,Watanabe T.,Sugiyama A.,Takemoto M.,Kawakami B.,Yamazaki M.,Watanabe K.,Kumagai A.,Itakura S.,Fukuzumi Y.,Fujimori Y.,Komiyama M.,Tashiro H.,Tanigami A.,Fujiwara T.,Ono T.,Yamada K.,Fujii Y.,Ozaki K.,Hirao M.,Ohmori Y.,Kawabata A.,Hikiji T.,Kobatake N.,Inagaki H.,Ikema Y.,Okamoto S.,Okitani R.,Kawakami T.,Noguchi S.,Itoh T.,Shigeta K.,Senba T.,Matsumura K.,Nakajima Y.,Mizuno T.,Morinaga M.,Sasaki M.,Togashi T.,Oyama M.,Hata H.,Watanabe M.,Komatsu T.,Mizushima-Sugano J.,Satoh T.,Shirai Y.,Takahashi Y.,Nakagawa K.,Okumura K.,Nagase T.,Nomura N.,Kikuchi H.,Masuho Y.,Yamashita R.,Nakai K.,Yada T.,Nakamura Y.,Ohara O.,Isogai T.,Sugano S.
Complete sequencing and characterization of 21,243 full-length human cDNAs.
Nat. Genet.
36
40-45
2004
96699
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
Genome Res.
14
2121-2127
2004
96701
Thigpen A.E.,Davis D.L.,Milatovich A.,Mendonca B.B.,Imperato-Mcginley J.,Griffin J.E.,Francke U.,Wilson J.D.,Russell D.W.
Molecular genetics of steroid 5 alpha-reductase 2 deficiency.
J. Clin. Invest.
90
799-809
1992
96702
Boudon C.,Lobaccaro J.-M.,Lumbroso S.,Ogur G.,Ocal G.,Belon C.,Sultan C.
A new deletion of the 5-alpha-reductase type 2 gene in a Turkish family with 5-alpha-reductase deficiency.
Clin. Endocrinol. (Oxf.)
43
183-188
1995
96703
Cai L.-Q.,Zhu Y.-S.,Katz M.D.,Herrera C.,Baez J.,DeFillo-Ricart M.,Shackleton C.H.L.,Imperato-McGinley J.
5-alpha-reductase-2 gene mutations in the Dominican Republic.
J. Clin. Endocrinol. Metab.
81
1730-1735
1996
96704
Hochberg Z.,Chayen R.,Reiss N.,Falik Z.,Makler A.,Munichor M.,Farkas A.,Goldfarb H.,Ohana N.,Hiort O.
Clinical, biochemical, and genetic findings in a large pedigree of male and female patients with 5-alpha-reductase 2 deficiency.
J. Clin. Endocrinol. Metab.
81
2821-2827
1996
96705
Anwar R.,Gilbey S.G.,New J.P.,Markham A.F.
Male pseudohermaphroditism resulting from a novel mutation in the human steroid 5 alpha-reductase type 2 gene (SRD5A2).
Mol. Pathol.
50
51-52
1997
96706
Nordenskjold A.,Magnus O.,Aagenaes O.,Knudtzon J.
Homozygous mutation (A228T) in the 5-alpha-reductase type 2 gene in a boy with 5-alpha-reductase deficiency: genotype-phenotype correlations.
Am. J. Med. Genet.
80
269-272
1998
96707
Nordenskjold A.,Ivarsson S.-A.
Molecular characterization of 5-alpha-reductase type 2 deficiency and fertility in a Swedish family.
J. Clin. Endocrinol. Metab.
83
3236-3238
1998
96708
Makridakis N.M.,Ross R.K.,Pike M.C.,Crocitto L.E.,Kolonel L.N.,Pearce C.L.,Henderson B.E.,Reichardt J.K.V.
Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA.
Lancet
354
975-978
1999
96709
Vilchis F.,Mendez J.P.,Canto P.,Lieberman E.,Chavez B.
Identification of missense mutations in the SRD5A2 gene from patients with steroid 5alpha-reductase 2 deficiency.
Clin. Endocrinol. (Oxf.)
52
383-387
2000
96710
Chavez B.,Valdez E.,Vilchis F.
Uniparental disomy in steroid 5-alpha-reductase 2 deficiency.
J. Clin. Endocrinol. Metab.
85
3147-3150
2000
96711
Makridakis N.M.,di Salle E.,Reichardt J.K.
Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II.
Pharmacogenetics
10
407-413
2000
96712
Pearce C.L.,Makridakis N.M.,Ross R.K.,Pike M.C.,Kolonel L.N.,Henderson B.E.,Reichardt J.K.V.
Steroid 5-alpha reductase type II V89L substitution is not associated with risk of prostate cancer in a multiethnic population study.
Cancer Epidemiol. Biomarkers Prev.
11
417-418
2002
96713
Sasaki G.,Ogata T.,Ishii T.,Kosaki K.,Sato S.,Homma K.,Takahashi T.,Hasegawa T.,Matsuo N.
Micropenis and the 5alpha-reductase-2 (SRD5A2) gene: mutation and V89L polymorphism analysis in 81 Japanese patients.
J. Clin. Endocrinol. Metab.
88
3431-3436
2003
96714
Loukola A.,Chadha M.,Penn S.G.,Rank D.,Conti D.V.,Thompson D.,Cicek M.,Love B.,Bivolarevic V.,Yang Q.,Jiang Y.,Hanzel D.K.,Dains K.,Paris P.L.,Casey G.,Witte J.S.
Comprehensive evaluation of the association between prostate cancer and genotypes/haplotypes in CYP17A1, CYP3A4, and SRD5A2.
Eur. J. Hum. Genet.
12
321-332
2004
96715
Fernandez-Cancio M.,Rodo J.,Andaluz P.,Martinez de Osaba M.J.,Rodriguez-Hierro F.,Esteban C.,Carrascosa A.,Audi L.
Clinical, biochemical and morphologic diagnostic markers in an infant male pseudohermaphrodite patient with compound heterozygous mutations (G115D/R246W) in SRD5A2 gene.
Horm. Res.
62
259-264
2004
96716
Fernandez-Cancio M.,Nistal M.,Gracia R.,Molina M.A.,Tovar J.A.,Esteban C.,Carrascosa A.,Audi L.
Compound heterozygous mutations in the SRD5A2 gene exon 4 in a male pseudohermaphrodite patient of Chinese origin.
J. Androl.
25
412-416
2004
96717
Nicoletti A.,Baldazzi L.,Balsamo A.,Barp L.,Pirazzoli P.,Gennari M.,Radetti G.,Cacciari E.,Cicognani A.
SRD5A2 gene analysis in an Italian population of under-masculinized 46,XY subjects.
Clin. Endocrinol. (Oxf.)
63
375-380
2005
96718
Hackel C.,Oliveira L.E.,Ferraz L.F.,Tonini M.M.,Silva D.N.,Toralles M.B.,Stuchi-Perez E.G.,Guerra-Junior G.
New mutations, hotspots, and founder effects in Brazilian patients with steroid 5alpha-reductase deficiency type 2.
J. Mol. Med.
83
569-576
2005
96719
Bahceci M.,Ersay A.R.,Tuzcu A.,Hiort O.,Richter-Unruh A.,Gokalp D.
A novel missense mutation of 5-alpha reductase type 2 gene (SRD5A2) leads to severe male pseudohermaphroditism in a Turkish family.
Urology
66
407-410
2005